5 Stocks to Watch: Week of 7/20/2026

By Jessie Moore, Stock Researcher and Writer
July 17, 2026 2:25 PM UTC
5 Stocks to Watch: Week of 7/20/2026

The weekend is upon us! Get a leg up on the trading week ahead with these 5 hand-selected stocks, all with significant upside potential:

  • Hewlett Packard Enterprise (HPE): AI server leader with over 50% upside potential 
  • Bristol Myers Squibb (BMY): Strong buy support and a hefty dividend
  • Expedia Group (EXPE): #1 A-rated travel stock with 20%+ upside potential
  • Atlanticus Holdings (ATLC): Fintech leader with elite A-rated Sentiment grade
  • Nature's Sunshine Products (NATR): This wellness stock has nearly 60% upside potential 


A note from our sponsors...

Windfall Profit Potential For These 5 Summer Stocks From peak travel demand to the World Cup to home improvement season, summer drives the business behind each of these 5 companies. This free report covers the catalysts, fundamentals and analyst price targets. Click here to access your free copy.

1- Bristol Myers Squibb (NYSE: BMY)

While investors remain fixated on looming patent expirations, the company's fast-growing portfolio of cancer, immunology, and neuroscience drugs is taking over, creating a compelling mix of value, income, and long-term growth with a dividend yield approaching 4.3%.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $60.28 — get current quote

Max 1-year forecast: $75.00

Why we're watching:

  • BMY has solid, bullish coverage among the analysts we track, with 5 Strong Buy, and 6 Hold recommendations. See all recommendations here
  • For example, Guggenheim researcher Seamus Fernandez (a top 2% rated analyst) reiterated his Strong Buy rating with a price target that suggests roughly 25% upside potential from current levels.
  • Additionally, Piper Sandler researcher David Amsellem (a top 4% rated analyst) maintained his Strong Buy with a price target that implies the stock could see over 30% upside in the coming year.
  • If you’re interested in options trading, we recently featured BMY as our Smart Leverage pick of the week.
  • Industry ranking context: BMY is currently the #1 highest-rated stock in the General Drug Manufacturer industry, which has an Industry Rating of A.
  • Zen Ratings highlights: BMY earns an overall A rating, equal to a Strong Buy recommendation. Stocks in this topmost tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
  • Component Grades: BMY shines with an A for Value, reflecting its attractive valuation relative to both earnings power and the broader pharma sector, while maintaining strong Bs for Financials and Safety that underscore its stable cash generation and defensive business model. See all 7 Component Grades here

Side note: Want more trending stocks? Check this out.

2- Hewlett Packard (NYSE: HPE)

Hewlett Packard is capitalizing on a powerful wave of AI-driven demand. With a backlog approaching $6 billion fueled by enterprise AI spending and strong momentum in its Hybrid IT division, HPE is positioned at the intersection of cloud infrastructure and next-generation computing.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $44.82 — get current quote

Max 1-year forecast: $80.00

Why we're watching:

  • HPE has strong, bullish coverage among the analysts we track, with 8 Strong Buy, 2 Buy, and 6 Hold recommendations. See all recommendations here
  • For example, Citigroup researcher Asiya Merchant (a top 1% rated analyst) maintained a Strong Buy rating with a price target suggesting over 40% upside potential from current levels.
  • Likewise, Loop Capital researcher Ananda Baruah (a top 6% rated analyst) recently upgraded to Strong Buy with a price target suggesting the stock could see over 50% upside in the coming year. 
  • On top of that, it’s our latest Stock of the Week, with Editor-in-Chief Steve Reitmeister lauding the stock’s impressive earnings momentum and highlighting its recent dip as a potential entry point. See his full commentary here.
  • Industry ranking context: HPE is currently the #3 highest-rated stock in the Communication Equipment industry, which has an Industry Rating of B.
  • Zen Ratings highlights: HPE earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks with this rating represent the elite top 5% of all 4,600+ stocks tracked based on a rigorous 115-factor fundamental review.
  • Component Grades: HPE excels with A for Growth, reflecting explosive AI-fueled expansion prospects and strong analyst conviction, while maintaining a solid B for Momentum, and Sentiment as the stock rides secular technology tailwinds. See all 7 Component Grades here


A note from our sponsors...

The Core of a Winning Portfolio

The 7 Stocks to Buy and Hold Forever aren't just plays for the next quarter – they're built to deliver for decades. These are blue-chip companies with fortress balance sheets, elite dividend track records, and the staying power to outperform in bull and bear markets alike. Some are Dividend Kings, others are on the path there, and all are proven wealth compounding machines. Whether you're after steady income, capital growth, or both, this is the list long-term investors will want in their back pocket.

Download the full list now – before it disappears behind the paywall.


3- Expedia Group (NASDAQ: EXPE)

This travel giant is leveraging fully connected hotel technology and AI-driven insights to eliminate friction and improve revenue performance for partners, while its scalable platform continues to drive long-term growth.

Zen Rating: A (Strong Buy) see full analysis

Recent Price: $271.00 — get current quote

Max 1-year forecast: $350.00

Why we're watching:

  • EXPE has solid coverage among the analysts we track, with 6 Strong Buy and 12 Hold recommendations. See all recommendations here
  • For example, Argus Research researcher John Staszak (a top 16% rated analyst) maintained his Strong Buy rating with a price target that implies nearly 20% upside potential.
  • Separately, BTIG researcher Jake Fuller (a top 22% rated analyst, but below our typical mention threshold) reiterated his Strong Buy with a price target that suggests the stock could still see nearly 25% upside from current levels.
  • Interested in options trading? EXPE was a recent Smart Leverage pick. See the story here.
  • Industry ranking context: EXPE is currently the #1 highest-rated stock in the Travel industry, which has an Industry Rating of B.
  • Zen Ratings highlights: EXPE earns an overall A rating, which amounts to a Strong Buy recommendation. Stocks in this elite category represent the top 5% of our universe based on a rigorous 115-factor review covering value, growth, and quality.
  • Component Grades: EXPE excels with As for Value and Financials, reflecting its attractive valuation and robust cash flow generation, while maintaining a solid B for Growth as travel demand continues its post-pandemic expansion. See all 7 Component Grades here

4- Atlanticus Holdings (NASDAQ: ATLC)

This fintech company's scalable platform and underwriting advantage have driven impressive profitability and positioned it for long-term growth in the fintech sector.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $96.47 — get current quote

Max 1-year forecast: $179.00

Why we're watching:

  • ATLC has limited, but overall bullish, coverage among the analysts we track, with 3 Strong Buy and 1 Buy recommendations. See all recommendations here
  • The above analysts see significant upside potential — currently, the maximum forecast suggests the stock could see nearly 80% upside in the coming year. 
  • Industry ranking context: ATLC is currently the #1 highest-rated stock in the Credit Service industry, which has an Industry Rating of C.
  • Zen Ratings highlights: ATLC earns an overall A rating, equal to a Strong Buy recommendation. Stocks with this rating have historically beaten the S&P by delivering nearly 30% annual returns.
  • Component Grades: ATLC stands out with an elite A grade for Sentiment alongside solid Bs for Growth, Momentum, and Financials, reflecting strong analyst confidence, a scalable specialty lending platform, sustained upward price momentum, and a healthy balance sheet See all 7 Component Grades here

5- Nature's Sunshine Products (NASDAQ: NATR)

Nature's Sunshine Products manufactures and distributes nutritional supplements and personal care products globally. The company is attracting renewed analyst attention as it strengthens its digital business and reports solid performance across all regions.

Zen Rating: A (Strong Buy)see full analysis

Recent Price: $21.00 — get current quote

Max 1-year forecast: $33.00

Why we're watching:

  • NATR has limited, but overall bullish, coverage among the analysts we track, with 2 Strong Buy recommendations. See all recommendations here
  • For example, Canaccord Genuity researcher Susan Anderson (a top 14% rated analyst) recently maintained her Strong Buy rating with a price target that suggests the stock has nearly 60% upside potential from current levels.
  • NATR is also part of our market-beating Zen Investor portfolio and has been a past Stock of the Week pick owing to its excellent fundamentals.
  • Industry ranking context: NATR is currently the #2 highest-rated stock in the Food industry, which has an Industry Rating of C.
  • Zen Ratings highlights: NATR earns an overall A rating, equal to a Strong Buy recommendation. Stocks in this top tier have historically delivered nearly 30% annual returns, soundly beating the S&P.
  • Component Grade highlights: NATR excels with As for Artificial Intelligence, Sentiment, and Value, a combination that highlights the company's strong market positioning and attractive valuation in a growing wellness sector, while maintaining a solid B for Financials. See all 7 Component Grades here

What to Do Next?

Want to get in touch? Email us at news@wallstreetzen.com.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.